Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 12 March, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo

Insecticides India Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 8, 2025, 1:43 pm

Market Cap 1,793 Cr.
Current Price 606
High / Low 1,085/460
Stock P/E13.4
Book Value 377
Dividend Yield0.50 %
ROCE13.0 %
ROE10.5 %
Face Value 10.0
PEG Ratio1.59

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Insecticides India Ltd

Competitors of Insecticides India Ltd

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Epigral Ltd 7,799 Cr. 1,808 2,408/94022.5 3240.28 %17.5 %16.9 % 10.0
Dharmaj Crop Guard Ltd 663 Cr. 197 390/16519.6 1170.00 %14.5 %13.2 % 10.0
Bhaskar Agrochemicals Ltd 39.6 Cr. 76.0 122/46.117.5 29.20.00 %14.7 %13.4 % 10.0
Bhagiradha Chemicals & Industries Ltd 3,872 Cr. 297 448/151128 51.00.03 %8.71 %5.55 % 1.00
Best Agrolife Ltd 695 Cr. 296 756/24636.0 3201.01 %16.5 %18.1 % 10.0
Industry Average10,095.70 Cr1,496.0535.79421.930.41%13.25%14.87%7.25

All Competitor Stocks of Insecticides India Ltd

Quarterly Result

MetricDec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Sales 314278561582357302640696358272657627359
Expenses 295244502514333330594614332263585537331
Operating Profit 1934586823-284682269729029
OPM % 6%12%10%12%7%-9%7%12%7%3%11%14%8%
Other Income 1200004-015320
Interest 2113543332221
Depreciation 7776677778778
Profit before tax 1128516012-393972174668220
Tax % 25%20%25%25%25%-26%26%26%28%-95%25%25%25%
Net Profit 82238459-292953128496215
EPS in Rs 2.757.5612.8415.093.15-9.809.8117.994.152.7316.6020.815.07

Last Updated: February 28, 2025, 7:13 pm

Below is a detailed analysis of the quarterly data for Insecticides India Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

  • For Sales, as of Dec 2024, the value is ₹359.00 Cr.. The value appears to be declining and may need further review. It has decreased from 627.00 Cr. (Sep 2024) to ₹359.00 Cr., marking a decrease of 268.00 Cr..
  • For Expenses, as of Dec 2024, the value is ₹331.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 537.00 Cr. (Sep 2024) to ₹331.00 Cr., marking a decrease of 206.00 Cr..
  • For Operating Profit, as of Dec 2024, the value is ₹29.00 Cr.. The value appears to be declining and may need further review. It has decreased from 90.00 Cr. (Sep 2024) to ₹29.00 Cr., marking a decrease of 61.00 Cr..
  • For OPM %, as of Dec 2024, the value is 8.00%. The value appears to be declining and may need further review. It has decreased from 14.00% (Sep 2024) to 8.00%, marking a decrease of 6.00%.
  • For Other Income, as of Dec 2024, the value is ₹0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Sep 2024) to ₹0.00 Cr., marking a decrease of 2.00 Cr..
  • For Interest, as of Dec 2024, the value is ₹1.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.00 Cr. (Sep 2024) to ₹1.00 Cr., marking a decrease of 1.00 Cr..
  • For Depreciation, as of Dec 2024, the value is ₹8.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.00 Cr. (Sep 2024) to ₹8.00 Cr., marking an increase of ₹1.00 Cr..
  • For Profit before tax, as of Dec 2024, the value is ₹20.00 Cr.. The value appears to be declining and may need further review. It has decreased from 82.00 Cr. (Sep 2024) to ₹20.00 Cr., marking a decrease of 62.00 Cr..
  • For Tax %, as of Dec 2024, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 25.00%.
  • For Net Profit, as of Dec 2024, the value is ₹15.00 Cr.. The value appears to be declining and may need further review. It has decreased from 62.00 Cr. (Sep 2024) to ₹15.00 Cr., marking a decrease of 47.00 Cr..
  • For EPS in Rs, as of Dec 2024, the value is 5.07. The value appears to be declining and may need further review. It has decreased from ₹20.81 (Sep 2024) to 5.07, marking a decrease of ₹15.74.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 3:55 pm

MetricMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales 5668018929069941,0731,1941,3631,4201,5041,8011,9661,916
Expenses 4987197818158809251,0061,2071,2681,3331,6791,8031,716
Operating Profit 688211191114148188156153171122163200
OPM % 12%10%12%10%11%14%16%11%11%11%7%8%10%
Other Income 10004302-231109
Interest 17273326201615247713117
Depreciation 671416161720242526262930
Profit before tax 464964508211815311011914184133172
Tax % 24%18%15%21%28%29%20%22%22%24%25%23%
Net Profit 354055395984122869310763103134
EPS in Rs 12.3914.0119.2412.6719.1627.0939.4927.7530.1436.1621.2834.6745.21
Dividend Payout % 11%10%0%11%7%5%3%10%4%6%14%9%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)14.29%37.50%-29.09%51.28%42.37%45.24%-29.51%8.14%15.05%-41.12%63.49%
Change in YoY Net Profit Growth (%)0.00%23.21%-66.59%80.37%-8.91%2.87%-74.75%37.65%6.91%-56.18%104.61%

Insecticides India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

No data available for the compounded sales growth chart.

Balance Sheet

Last Updated: November 14, 2024, 10:33 pm

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital 13131321212121212120303030
Reserves 2002342793884445276417107988478869821,087
Borrowings 211258322206237114305191100541638766
Other Liabilities 209287308322277338388372505473615611627
Total Liabilities 6327919219369781,0001,3551,2931,4241,3941,6941,7101,809
Fixed Assets 140170205194185232240239239253262283293
CWIP 45543851581719395991123141136
Investments 0111111111612101213151921
Other Assets 4475566676807257351,0841,0041,1151,0371,2931,2671,359
Total Assets 6327919219369781,0001,3551,2931,4241,3941,6941,7101,809

Below is a detailed analysis of the balance sheet data for Insecticides India Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2024, the value is ₹30.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹30.00 Cr..
  • For Reserves, as of Sep 2024, the value is ₹1,087.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹982.00 Cr. (Mar 2024) to ₹1,087.00 Cr., marking an increase of 105.00 Cr..
  • For Borrowings, as of Sep 2024, the value is ₹66.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from ₹87.00 Cr. (Mar 2024) to ₹66.00 Cr., marking a decrease of 21.00 Cr..
  • For Other Liabilities, as of Sep 2024, the value is ₹627.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹611.00 Cr. (Mar 2024) to ₹627.00 Cr., marking an increase of 16.00 Cr..
  • For Total Liabilities, as of Sep 2024, the value is ₹1,809.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹1,710.00 Cr. (Mar 2024) to ₹1,809.00 Cr., marking an increase of 99.00 Cr..
  • For Fixed Assets, as of Sep 2024, the value is ₹293.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹283.00 Cr. (Mar 2024) to ₹293.00 Cr., marking an increase of 10.00 Cr..
  • For CWIP, as of Sep 2024, the value is ₹136.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹141.00 Cr. (Mar 2024) to ₹136.00 Cr., marking a decrease of 5.00 Cr..
  • For Investments, as of Sep 2024, the value is ₹21.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹19.00 Cr. (Mar 2024) to ₹21.00 Cr., marking an increase of 2.00 Cr..
  • For Other Assets, as of Sep 2024, the value is ₹1,359.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹1,267.00 Cr. (Mar 2024) to ₹1,359.00 Cr., marking an increase of 92.00 Cr..
  • For Total Assets, as of Sep 2024, the value is ₹1,809.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹1,710.00 Cr. (Mar 2024) to ₹1,809.00 Cr., marking an increase of 99.00 Cr..

Notably, the Reserves (₹1,087.00 Cr.) exceed the Borrowings (66.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +-138-6854182-133242155135-11185
Cash from Investing Activity +-46-57-33-19-14-26-49-24-1139-87-44
Cash from Financing Activity +352336-639-143172-159-104-11580-98
Net Cash Flow-134-23-013-1159-6130-1843

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow-143.00-176.00-211.00-115.00-123.0034.00-117.00-35.0053.00117.00-41.0076.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days755868847880758665706055
Inventory Days221189220190232214355202248228247220
Days Payable12812411811410812814196136117128114
Cash Conversion Cycle168124170159201166289192177181178161
Working Capital Days147115138137155126206147132123124109
ROCE %16%16%17%12%16%20%21%14%15%16%10%13%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Promoters72.16%72.16%72.16%72.16%72.16%72.16%72.16%72.16%72.16%72.16%72.16%72.30%
FIIs5.42%6.66%6.32%6.27%6.46%6.02%5.19%4.41%4.31%4.36%5.43%5.13%
DIIs8.91%10.98%10.94%10.94%10.77%10.53%9.36%9.12%9.14%9.08%9.06%9.24%
Public13.51%10.20%10.58%10.64%10.62%11.30%13.31%14.32%14.40%14.41%13.36%13.34%
No. of Shareholders15,40114,23320,22319,18916,35518,01218,86818,23219,25219,47422,48422,849

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
HDFC Small Cap Fund - Regular Plan2,596,8000.58133.422,596,8002025-03-100%
HDFC Retirement Savings Fund - Hybrid Debt - Regular Plan4,2000.140.222,596,8002025-03-10-99.84%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 34.5921.3654.1745.4342.05
Diluted EPS (Rs.) 34.5921.3654.1745.4342.05
Cash EPS (Rs.) 44.3630.1067.5957.1453.28
Book Value[Excl.RevalReserv]/Share (Rs.) 342.44310.26440.71396.93354.04
Book Value[Incl.RevalReserv]/Share (Rs.) 342.44310.26440.71396.93354.04
Revenue From Operations / Share (Rs.) 664.37608.60762.20687.17659.59
PBDIT / Share (Rs.) 58.1241.6188.1677.4476.65
PBIT / Share (Rs.) 48.2432.7974.8065.5165.00
PBT / Share (Rs.) 44.5628.2471.4457.5953.45
Net Profit / Share (Rs.) 34.4821.2854.2445.2141.63
NP After MI And SOA / Share (Rs.) 34.5921.3654.4445.4342.05
PBDIT Margin (%) 8.746.8311.5611.2611.62
PBIT Margin (%) 7.265.389.819.539.85
PBT Margin (%) 6.704.649.378.388.10
Net Profit Margin (%) 5.183.497.116.576.31
NP After MI And SOA Margin (%) 5.203.507.146.616.37
Return on Networth / Equity (%) 10.096.8812.3511.4411.87
Return on Capital Employeed (%) 13.5010.3516.6116.0917.79
Return On Assets (%) 5.973.727.696.586.71
Long Term Debt / Equity (X) 0.020.000.000.000.00
Total Debt / Equity (X) 0.080.170.050.110.25
Asset Turnover Ratio (%) 1.151.161.071.041.03
Current Ratio (X) 1.901.621.971.861.81
Quick Ratio (X) 0.670.480.730.720.85
Inventory Turnover Ratio (X) 1.601.881.611.771.29
Dividend Payout Ratio (NP) (%) 8.6723.410.004.4014.26
Dividend Payout Ratio (CP) (%) 6.7416.560.003.4811.17
Earning Retention Ratio (%) 91.3376.590.0095.6085.74
Cash Earning Retention Ratio (%) 93.2683.440.0096.5288.83
Interest Coverage Ratio (X) 15.809.1626.2224.066.63
Interest Coverage Ratio (Post Tax) (X) 10.375.6817.1316.514.60
Enterprise Value (Cr.) 1468.531522.181224.20990.06758.34
EV / Net Operating Revenue (X) 0.740.840.810.690.55
EV / EBITDA (X) 8.5412.367.046.194.79
MarketCap / Net Operating Revenue (X) 0.730.760.800.680.47
Retention Ratios (%) 91.3276.580.0095.5985.73
Price / BV (X) 1.431.511.391.190.88
Price / Net Operating Revenue (X) 0.730.760.800.680.47
EarningsYield 0.070.040.080.090.13

After reviewing the key financial ratios for Insecticides India Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
  • For Basic EPS (Rs.), as of Mar 24, the value is 34.59. This value is within the healthy range. It has increased from 21.36 (Mar 23) to 34.59, marking an increase of 13.23.
  • For Diluted EPS (Rs.), as of Mar 24, the value is 34.59. This value is within the healthy range. It has increased from 21.36 (Mar 23) to 34.59, marking an increase of 13.23.
  • For Cash EPS (Rs.), as of Mar 24, the value is 44.36. This value is within the healthy range. It has increased from 30.10 (Mar 23) to 44.36, marking an increase of 14.26.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 342.44. It has increased from 310.26 (Mar 23) to 342.44, marking an increase of 32.18.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 342.44. It has increased from 310.26 (Mar 23) to 342.44, marking an increase of 32.18.
  • For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 664.37. It has increased from 608.60 (Mar 23) to 664.37, marking an increase of 55.77.
  • For PBDIT / Share (Rs.), as of Mar 24, the value is 58.12. This value is within the healthy range. It has increased from 41.61 (Mar 23) to 58.12, marking an increase of 16.51.
  • For PBIT / Share (Rs.), as of Mar 24, the value is 48.24. This value is within the healthy range. It has increased from 32.79 (Mar 23) to 48.24, marking an increase of 15.45.
  • For PBT / Share (Rs.), as of Mar 24, the value is 44.56. This value is within the healthy range. It has increased from 28.24 (Mar 23) to 44.56, marking an increase of 16.32.
  • For Net Profit / Share (Rs.), as of Mar 24, the value is 34.48. This value is within the healthy range. It has increased from 21.28 (Mar 23) to 34.48, marking an increase of 13.20.
  • For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 34.59. This value is within the healthy range. It has increased from 21.36 (Mar 23) to 34.59, marking an increase of 13.23.
  • For PBDIT Margin (%), as of Mar 24, the value is 8.74. This value is below the healthy minimum of 10. It has increased from 6.83 (Mar 23) to 8.74, marking an increase of 1.91.
  • For PBIT Margin (%), as of Mar 24, the value is 7.26. This value is below the healthy minimum of 10. It has increased from 5.38 (Mar 23) to 7.26, marking an increase of 1.88.
  • For PBT Margin (%), as of Mar 24, the value is 6.70. This value is below the healthy minimum of 10. It has increased from 4.64 (Mar 23) to 6.70, marking an increase of 2.06.
  • For Net Profit Margin (%), as of Mar 24, the value is 5.18. This value is within the healthy range. It has increased from 3.49 (Mar 23) to 5.18, marking an increase of 1.69.
  • For NP After MI And SOA Margin (%), as of Mar 24, the value is 5.20. This value is below the healthy minimum of 8. It has increased from 3.50 (Mar 23) to 5.20, marking an increase of 1.70.
  • For Return on Networth / Equity (%), as of Mar 24, the value is 10.09. This value is below the healthy minimum of 15. It has increased from 6.88 (Mar 23) to 10.09, marking an increase of 3.21.
  • For Return on Capital Employeed (%), as of Mar 24, the value is 13.50. This value is within the healthy range. It has increased from 10.35 (Mar 23) to 13.50, marking an increase of 3.15.
  • For Return On Assets (%), as of Mar 24, the value is 5.97. This value is within the healthy range. It has increased from 3.72 (Mar 23) to 5.97, marking an increase of 2.25.
  • For Long Term Debt / Equity (X), as of Mar 24, the value is 0.02. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 23) to 0.02, marking an increase of 0.02.
  • For Total Debt / Equity (X), as of Mar 24, the value is 0.08. This value is within the healthy range. It has decreased from 0.17 (Mar 23) to 0.08, marking a decrease of 0.09.
  • For Asset Turnover Ratio (%), as of Mar 24, the value is 1.15. It has decreased from 1.16 (Mar 23) to 1.15, marking a decrease of 0.01.
  • For Current Ratio (X), as of Mar 24, the value is 1.90. This value is within the healthy range. It has increased from 1.62 (Mar 23) to 1.90, marking an increase of 0.28.
  • For Quick Ratio (X), as of Mar 24, the value is 0.67. This value is below the healthy minimum of 1. It has increased from 0.48 (Mar 23) to 0.67, marking an increase of 0.19.
  • For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.60. This value is below the healthy minimum of 4. It has decreased from 1.88 (Mar 23) to 1.60, marking a decrease of 0.28.
  • For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 8.67. This value is below the healthy minimum of 20. It has decreased from 23.41 (Mar 23) to 8.67, marking a decrease of 14.74.
  • For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 6.74. This value is below the healthy minimum of 20. It has decreased from 16.56 (Mar 23) to 6.74, marking a decrease of 9.82.
  • For Earning Retention Ratio (%), as of Mar 24, the value is 91.33. This value exceeds the healthy maximum of 70. It has increased from 76.59 (Mar 23) to 91.33, marking an increase of 14.74.
  • For Cash Earning Retention Ratio (%), as of Mar 24, the value is 93.26. This value exceeds the healthy maximum of 70. It has increased from 83.44 (Mar 23) to 93.26, marking an increase of 9.82.
  • For Interest Coverage Ratio (X), as of Mar 24, the value is 15.80. This value is within the healthy range. It has increased from 9.16 (Mar 23) to 15.80, marking an increase of 6.64.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 10.37. This value is within the healthy range. It has increased from 5.68 (Mar 23) to 10.37, marking an increase of 4.69.
  • For Enterprise Value (Cr.), as of Mar 24, the value is 1,468.53. It has decreased from 1,522.18 (Mar 23) to 1,468.53, marking a decrease of 53.65.
  • For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.74. This value is below the healthy minimum of 1. It has decreased from 0.84 (Mar 23) to 0.74, marking a decrease of 0.10.
  • For EV / EBITDA (X), as of Mar 24, the value is 8.54. This value is within the healthy range. It has decreased from 12.36 (Mar 23) to 8.54, marking a decrease of 3.82.
  • For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.73. This value is below the healthy minimum of 1. It has decreased from 0.76 (Mar 23) to 0.73, marking a decrease of 0.03.
  • For Retention Ratios (%), as of Mar 24, the value is 91.32. This value exceeds the healthy maximum of 70. It has increased from 76.58 (Mar 23) to 91.32, marking an increase of 14.74.
  • For Price / BV (X), as of Mar 24, the value is 1.43. This value is within the healthy range. It has decreased from 1.51 (Mar 23) to 1.43, marking a decrease of 0.08.
  • For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.73. This value is below the healthy minimum of 1. It has decreased from 0.76 (Mar 23) to 0.73, marking a decrease of 0.03.
  • For EarningsYield, as of Mar 24, the value is 0.07. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 23) to 0.07, marking an increase of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Insecticides India Ltd as of March 12, 2025 is: ₹426.47

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 12, 2025, Insecticides India Ltd is Overvalued by 29.63% compared to the current share price 606.00

Intrinsic Value of Insecticides India Ltd as of March 12, 2025 is: 462.49

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 12, 2025, Insecticides India Ltd is Overvalued by 23.68% compared to the current share price 606.00

Last 5 Year EPS CAGR: 8.45%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 15.50%, which is a positive sign.
  2. The company has higher reserves (617.15 cr) compared to borrowings (178.00 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (320.54 cr) and profit (101.62 cr) over the years.
  1. The stock has a high average Working Capital Days of 138.25, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 180.50, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Insecticides India Ltd:
    1. Net Profit Margin: 5.18%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 13.5% (Industry Average ROCE: 13.25%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 10.09% (Industry Average ROE: 14.87%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 10.37
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 0.67
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 13.4 (Industry average Stock P/E: 35.79)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.08
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Insecticides (India) Ltd. is a Public Limited Listed company incorporated on 18/12/1996 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L65991DL1996PLC083909 and registration number is 083909. Currently Company is involved in the business activities of Manufacture of pesticides and other agrochemical products. Company's Total Operating Revenue is Rs. 1966.39 Cr. and Equity Capital is Rs. 29.60 Cr. for the Year ended 31/03/2024.
INDUSTRYADDRESSCONTACT
Agro Chemicals/Pesticides401-402, Lusa Tower, Delhi Delhi 110033investor@insecticidesindia.com
http://www.insecticidesindia.com
Management
NamePosition Held
Mr. Hari Chand AggarwalChairman & Wholetime Director
Mr. Rajesh Kumar AggarwalManaging Director
Mr. Nikunj AggarwalWhole Time Director
Mr. Anil Kumar GoyalWhole Time Director
Ms. Praveen GuptaIndependent Director
Mr. Anil Kumar BhatiaIndependent Director
Mr. Shyam Lal BansalIndependent Director
Mr. Supratim BandyopadhayIndependent Director

FAQ

What is the latest intrinsic value of Insecticides India Ltd?

The latest intrinsic value of Insecticides India Ltd as on 09 March 2025 is ₹426.47, which is 29.63% lower than the current market price of 606.00, indicating the stock is overvalued by 29.63%. The intrinsic value of Insecticides India Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹1,793 Cr. and recorded a high/low of ₹1,085/460 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹1,087 Cr and total liabilities of ₹1,809 Cr.

What is the Market Cap of Insecticides India Ltd?

The Market Cap of Insecticides India Ltd is 1,793 Cr..

What is the current Stock Price of Insecticides India Ltd as on 09 March 2025?

The current stock price of Insecticides India Ltd as on 09 March 2025 is ₹606.

What is the High / Low of Insecticides India Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Insecticides India Ltd stocks is ₹1,085/460.

What is the Stock P/E of Insecticides India Ltd?

The Stock P/E of Insecticides India Ltd is 13.4.

What is the Book Value of Insecticides India Ltd?

The Book Value of Insecticides India Ltd is 377.

What is the Dividend Yield of Insecticides India Ltd?

The Dividend Yield of Insecticides India Ltd is 0.50 %.

What is the ROCE of Insecticides India Ltd?

The ROCE of Insecticides India Ltd is 13.0 %.

What is the ROE of Insecticides India Ltd?

The ROE of Insecticides India Ltd is 10.5 %.

What is the Face Value of Insecticides India Ltd?

The Face Value of Insecticides India Ltd is 10.0.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Insecticides India Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE